{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:13:19Z","timestamp":1774620799475,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"DOI":"10.7759\/cureus.105969","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:08:01Z","timestamp":1774616881000},"source":"Crossref","is-referenced-by-count":0,"title":["Uptake of Technetium-99m Sestamibi (99mTc-MIBI) as a Predictor of Fracture Risk in the Appendicular Skeleton of Multiple Myeloma Patients at a National Reference Center"],"prefix":"10.7759","author":[{"given":"Reyna Sarahi","family":"Ba\u00f1uelos Balderas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Miguel","family":"Linares Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Antonio","family":"Arguelles P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monserrat G","family":"Bastidas Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos D","family":"Baranzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luisa","family":"Galicia-Zamalloa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1157\/13107365","article-title":"Multiple myeloma [Article in Spanish]","volume":"129","author":"Garc\u00eda-Sanz R","year":"2007","unstructured":"Garc\u00eda-Sanz R, Mateos MV, San Miguel JF. Multiple myeloma [Article in Spanish]. Med Clin (Barc). 2007, 129:104-15. 10.1157\/13107365","journal-title":"Med Clin (Barc)"},{"key":"ref2","unstructured":"Multiple myeloma. https.\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/35-multiple-myeloma-fact-sheet.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-010-1088-9","article-title":"The value of FDG PET\/CT in the initial staging and bone marrow involvement of patients with multiple myeloma","volume":"40","author":"Sager S","year":"2011","unstructured":"Sager S, Erg\u00fcl N, Ciftci H, Cetin G, G\u00fcner SI, Cermik TF. The value of FDG PET\/CT in the initial staging and bone marrow involvement of patients with multiple myeloma. Skeletal Radiol. 2011, 40:843-7. 10.1007\/s00256-010-1088-9","journal-title":"Skeletal Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar SV","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022, 97:1086-107. 10.1002\/ajh.26590","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma","volume":"49","author":"Fonti R","year":"2008","unstructured":"Fonti R, Salvatore B, Quarantelli M, et al.. 18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. J Nucl Med. 2008, 49:195-200. 10.2967\/jnumed.107.045641","journal-title":"J Nucl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2011.584589","article-title":"Characterizing and predicting pathologic spine fractures in myeloma patients with FDG PET\/CT and MR imaging","volume":"29","author":"Mulligan M","year":"2011","unstructured":"Mulligan M, Chirindel A, Karchevsky M. Characterizing and predicting pathologic spine fractures in myeloma patients with FDG PET\/CT and MR imaging. Cancer Invest. 2011, 29:370-6. 10.3109\/07357907.2011.584589","journal-title":"Cancer Invest"},{"key":"ref7","article-title":"Prediction of long bone fractures in multiple myeloma patients in an advanced imaging world","volume":"23","author":"Or O","year":"2021","unstructured":"Or O, Saiyed R, Marty E, Boyer A, Jahnwar YS, Niesvizky R, Lane JM. Prediction of long bone fractures in multiple myeloma patients in an advanced imaging world. Isr Med Assoc J. 2021, 23:501-5.","journal-title":"Isr Med Assoc J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2022.10.008","article-title":"Clinical value of FDG-PET\/CT in multiple myeloma: an update","volume":"53","author":"Bezzi D","year":"2023","unstructured":"Bezzi D, Ambrosini V, Nanni C. Clinical value of FDG-PET\/CT in multiple myeloma: an update. Semin Nucl Med. 2023, 53:352-70. 10.1053\/j.semnuclmed.2022.10.008","journal-title":"Semin Nucl Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01327-4","article-title":"Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma","volume":"15","author":"Messiou C","year":"2025","unstructured":"Messiou C, Porta N, Koh DM, et al.. Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma. Blood Cancer J. 2025, 15:122. 10.1038\/s41408-025-01327-4","journal-title":"Blood Cancer J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group","volume":"22","author":"Terpos E","year":"2021","unstructured":"Terpos E, Zamagni E, Lentzsch S, et al.. Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group. Lancet Oncol. 2021, 22:119-30. 10.1016\/S1470-2045(20)30559-3","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06858-9","article-title":"EANM guidelines on the use of [18F]FDG PET\/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders","volume":"52","author":"Nanni C","year":"2024","unstructured":"Nanni C, Deroose CM, Balogova S, et al.. EANM guidelines on the use of [18F]FDG PET\/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders. Eur J Nucl Med Mol Imaging. 2024, 52:171-92. 10.1007\/s00259-024-06858-9","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429112-uptake-of-technetium-99m-sestamibi-99mtc-mibi-as-a-predictor-of-fracture-risk-in-the-appendicular-skeleton-of-multiple-myeloma-patients-at-a-national-reference-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:08:04Z","timestamp":1774616884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429112-uptake-of-technetium-99m-sestamibi-99mtc-mibi-as-a-predictor-of-fracture-risk-in-the-appendicular-skeleton-of-multiple-myeloma-patients-at-a-national-reference-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.105969","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}